obacunone has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Guo, Y; Hao, D; He, B; Hu, H; Huang, Y; Jian, B; Sun, K; Wang, X; Zhu, J | 1 |
1 other study(ies) available for obacunone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Obacunone inhibits RANKL/M-CSF-mediated osteoclastogenesis by suppressing integrin- FAK-Src signaling.
Topics: Animals; Bone Resorption; Cell Differentiation; Female; Focal Adhesion Protein-Tyrosine Kinases; Integrin alpha1; Macrophage Colony-Stimulating Factor; Mice; Osteoclasts; Osteogenesis; Osteoporosis; RANK Ligand; Receptors, Steroid | 2023 |